Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia.
about
Defining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 2: Underlying biological mechanisms.New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeuticsModulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment.Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease.Impact of diabetes on the natural history of tuberculosis.Macrophage immunoregulatory pathways in tuberculosis.The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosis.NK-CD11c+ Cell Crosstalk in Diabetes Enhances IL-6-Mediated Inflammation during Mycobacterium tuberculosis Infection.Respiratory Burst Process in Diabetic Children.Brief Report: HIV-1 Infection Impairs CD16 and CD35 Mediated Opsonophagocytosis of Mycobacterium tuberculosis by Human Neutrophils.Diabetes and Tuberculosis.Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus.Profiling leucocyte subsets in tuberculosis-diabetes co-morbidity.In vitro infection with Mycobacterium tuberculosis induces a distinct immunological pattern in blood from healthy relatives of tuberculosis patients.The burden of common infections in children and adolescents with diabetes mellitus: A Pediatric Health Information System study.Impaired Inflammatory Response to LPS in Type 2 Diabetes Mellitus.Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis.
P2860
Q30234697-F2F6BFE3-522F-4DC3-8560-83CB3B4F5D76Q30371980-4AE2C89C-1833-4597-B175-E84FCF2402C4Q30395402-E7C4DB27-3795-40A5-9E34-F803055F5D3FQ33583012-CD5FDDAD-DBB2-47DB-9BEC-E024EDDE6C59Q34663669-39C9C266-A991-4455-9A63-2EBD2F061B8DQ35039679-7497E76B-D31A-4319-8AD6-44207361FB6BQ35558240-54ED61FB-8C74-472D-B900-5EB456D6D407Q36175034-8DD2C8BE-09AB-4B87-90FF-E4FAAD15F7E5Q37191703-B12BCBEE-6796-4226-8A65-C8B7B3BF0E5DQ37246262-84E39970-E33D-476B-B2DC-7A70BCE8B7F6Q37590128-60A26BC8-4B72-4513-AB69-35344282E217Q38363794-E8D05644-8E1E-4194-9B26-715D09C0E094Q40815734-4E8932FC-1EB0-4454-BC15-2EF935097BF2Q46280625-B8D5EEF4-C691-46DA-896F-AAEFFFD67ED4Q47671574-7F4AF29C-4902-4051-A957-C33F23231FA8Q54250439-D9C4C286-C41F-4318-9679-7B54709B8B9EQ55333182-525F3C04-129C-475E-9395-44155A7A4B0F
P2860
Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phagocytosis via complement or ...... ts with chronic hyperglycemia.
@ast
Phagocytosis via complement or ...... ts with chronic hyperglycemia.
@en
type
label
Phagocytosis via complement or ...... ts with chronic hyperglycemia.
@ast
Phagocytosis via complement or ...... ts with chronic hyperglycemia.
@en
prefLabel
Phagocytosis via complement or ...... ts with chronic hyperglycemia.
@ast
Phagocytosis via complement or ...... ts with chronic hyperglycemia.
@en
P2093
P2860
P921
P1433
P1476
Phagocytosis via complement or ...... ts with chronic hyperglycemia.
@en
P2093
Blanca I Restrepo
Larry S Schlesinger
Marcel Twahirwa
Mohammad H Rahbar
P2860
P304
P356
10.1371/JOURNAL.PONE.0092977
P407
P577
2014-03-26T00:00:00Z